UltraSight develops AI guidance and workflow software that helps clinicians acquire cardiac ultrasound images at the point of care.
CI
Connecticut Innovations
Activity from announced rounds
Activity in this selectionUnited States · Oct 9, 2026 · Jan 1, 2026
- Rounds participated in
- 8
- Confirmed lead rounds
- 0 7 roles undisclosed
- New companies
- 8 First participation on record · 0 follow-on
- Funding in participating rounds
- $120M 7 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
8 in this selectionUltraSight
$24MSeries B2
ParticipantQueen One
AI-governed Commerce CRM platform combining identity, product and creative intelligence for brands
$25MSeries A
Role not disclosedRejuvenate Bio
Develops gene therapies for age-related and chronic diseases in animals and humans
$6MStrategic
Role not disclosedP2 Science
Designs and manufactures renewable specialty ingredients for personal care, fragrance, and performance materials
$23MUndisclosed
Role not disclosedVortex Imaging
Develops a compact computational ultrasound system for standardized 3D volumetric imaging at the point of care
$12MUndisclosed
Role not disclosedCREW Carbon
Provides wastewater treatment optimization technology that lowers costs and permanently removes CO2
$25MSeries A
Role not disclosedMongoose AI
Provides governed AI agents for health plans to execute work across every interaction
UndisclosedSeed+
Role not disclosedQuorus
Provides custom, tax‑managed portfolio infrastructure and operational support for active asset managers
$5MSeed
Role not disclosed